There are multiple ways for individuals to provide vaccination status documentation:
Employees: An employee can upload a scan or photo of the front side of their vaccination card directly into the HR Solutions Hub. The employee can email the scan or photo to OHSRequests@exeloncorp.com. An employee should include their six-digit employee ID number and front side of the card in the e-mail. Each operating company has communicated applicable ways for employees to provide vaccination status documentation.
Staff Augmentation Contractors: Staff augmentation workers should email OHSRequests@exeloncorp.com to provide vaccination documentation.
Other Contractors: Contractors, other than onsite staff augmentation providers, are managing their process of documenting vaccination status and distributing stickers/buttons separately. Contractors, other than staff augmentation, should not input their information into the HR Solutions Hub or email OHSRequests@exeloncorp.com with vaccination documentation.
Under Equal Employment Opportunity Commission (EEOC) COVID-19 vaccination guidance, it is permissible for employers to request vaccination status, provided they treat documentation provided by the employee as confidential medical information with appropriately restricted access. Because Exelon entities are requesting vaccination verification in their role as employers and employees are voluntarily providing the information, the information is not protected health information covered by the Health Insurance Portability and Accountability Act (HIPAA).
The sticker/button is a visible identifier that you are approved to work without a mask and not socially distance. The vaccination documentation you provide to the company will be treated as confidential medical information in the HR Solutions Hub.
No. Only employees who are fully vaccinated, provide vaccination documentation and have it confirmed by OHS can take advantage of the new rules about masks and social distancing. It is voluntary for you to do so.
No. Vaccinated status is not a protected classification under applicable anti-discrimination laws. Exelon is implementing the new safety protocols in accordance with CDC guidance, EEOC guidance, and state and local requirements.
If you are not vaccinated – regardless of the reason – you must continue to wear a mask and socially distance for your safety and the safety of all employees. Please see OHS if you are seeking accommodation of a disability or HR to request accommodation of a religious belief. Under EEOC guidance, wearing a mask is an example of a reasonable accommodation for an employee who cannot get vaccinated based on a disability or religious belief.
Some employees will get a button to pin on their shirts instead of a badge sticker due to the work they perform.
If you cannot display your sticker or button, you must wear a mask and stay socially distant.
By only holding the drawings if we reach certain percentage thresholds of employees who are vaccinated, we hope to encourage as many employees as possible to get vaccinated and help reach those thresholds.
For on-site employees, once OHS verifies your information, you will receive an approval email with instructions on how to obtain your sticker/button based on your location.
Remote employees will receive instructions on how to obtain their stickers during their phase of Re-Entry in a communication in early August. In the interim, remote employees who need to regularly visit an Exelon site may contact Site Safety for more details.
Getting vaccinated and verifying your vaccination by uploading your vaccination card is entirely up to you.
At the same time, to keep everyone safe, it’s important that only vaccinated employees who verify their status can take advantage of the easing of mask and social distancing restrictions in accordance with CDC guidance.
Many resources (scientists, researchers, and reputable agencies) worked together in a worldwide effort to deliver a vaccine to market. Additionally, the mRNA vaccines, the technology Pfizer and Moderna used, have been around for a couple of decades, which eliminated a lot of the pre-work that must go into vaccine production. The clinical trials were large with many thousands of people participating, which resulted in strong, reliable data.
Because vaccine facilities may differ across localities, it may be best to call your vaccine facility or visit their website prior to your appointment to confirm any other required items you need to bring.
If you are receiving your second dose of the vaccine, you should bring the vaccination card you received when you got your first dose. You may also be asked to show your medical insurance ID card and to complete a vaccine screening form to confirm your eligibility.
The mRNA vaccine trials did not deliberately include pregnant or breastfeeding individuals, so our direct knowledge is currently limited; however, some vaccine trial participants became pregnant during the trial.
Although the overall risk of sever illness from the vaccination is low, pregnant and recently pregnant people are more likely to get severely ill with COVID-19 compared to non-pregnant people; additionally, pregnant people with COVID-19 are at an increased risk of preterm birth compared to those without COVID-19. Further information may be available in coming months.
When studied during animal tests, the mRNA vaccines did not affect fertility or cause any problems with pregnancy. In humans, we know that other kinds of vaccines generally are safe for use in pregnancy — in fact, many are recommended. Additionally, early data from the CDC and FDA safety monitoring systems has not identified any safety concerns for pregnant people who were vaccinated or their babies.
The Centers for Disease Control and Prevention (CDC), the American College of Obstetricians and Gynecologists (ACOG), and the Society for Maternal-Fetal Medicine agree that the new mRNA COVID-19 vaccines should be offered to pregnant individuals who are eligible for vaccination. You can weigh benefits and risks with your doctor.
Experts, including the WHO, believe it is most likely safe to get an mRNA COVID-19 vaccine if you’re breastfeeding. Although breastfeeding people were not included in the vaccine trials, the mechanism of mRNA vaccines and experience from other vaccines suggest this is true.
It is important to know:
The two COVID-19 vaccines available to us are designed to help your body’s immune system fight the coronavirus. The messenger RNA from two of the first types of COVID-19 vaccines does enter cells, but not the nucleus of the cells where DNA resides. The mRNA does its job to cause the cell to make protein to stimulate the immune system, and then it quickly breaks down — without affecting your DNA.
While we encourage everyone to get the vaccine, it’s your decision. The company is not planning to make the vaccine mandatory.
There are several strains of COVID. Even if you’ve had the virus, the vaccine will further boost your immune system to ensure protection
The Pfizer and Moderna COVID-19 vaccines don’t contain coronavirus, so the vaccinated person can’t get COVID-19 from the vaccine. But they may feel the side effects described in the question above or may have been exposed to and contracted COVID-19 (prior to the immunity from the vaccine becoming active) or another virus or bacteria around the time they got vaccinated.
The more people who get the vaccine, the sooner we can end the pandemic for everyone. While we encourage everyone to get the vaccine, it’s your decision. The Pfizer and Moderna vaccines have a two-shot regimen, with the second shot required 21 days (Pfizer) or 28 days (Moderna) after the first one. If you only get one of the shots, you will not achieve the full immunity offered by the two-shot regimen. Like the shingles vaccine you need to get both to establish immunity! Vaccines trigger an immune response in the body which can result in symptoms such as soreness, headaches and fever. While these should not concern you, you should be prepared. In any case, it is far better than contracting COVID and potentially suffering the long-term health effects.
The CDC recommends an age-appropriate COVID vaccine for those 12 years and older. Most people are experiencing mild side effects (fatigue, redness and soreness at the injection site, headaches or minor joint pain). Reports of serious side effects, such as blood clots or developing Guillain-Barre Syndrome with the J&J vaccine, remain rare.
The incidence of blood clots is very low – 28 out of 8.7 million J&J doses given through May, 2021, involved cerebral clots, mainly in women younger than age 50. The FDA and CDC have determined that the risk of severe clotting is generally higher from COVID-19 itself; and, therefor, the vaccine is recommended as the protection from COVID-19.
The incidence of developing Guillain-Barre Syndrome (GBS), a typically temporary but serious neurological disorder where the body's immune system damages nerve cells, is also very low – 100 among the 12.8 million J&J doses administered through July 13, 2021, and mainly impact men 50 and older. Cases have largely been reported about two weeks after vaccination but can occur as long as 42 days after vaccination. An estimated 3,000-6,000 people develop GBS each year and most of them fully recover. The CDC and FDA have determined that the health risks from COVID-19 itself are generally higher; and, therefor, the vaccine remains recommended.
If you have questions about side effects, a history of GBS or a concern about how the vaccine may affect you, please contact your health care provider.
Your uploaded card and the information on the vaccination card (or other documentation) will be used to verify your eligibility for this exception to safety protocols, and for follow up communications such as alerts about the need for a booster vaccine to continue to take advantage of this exception. Vaccination documentation provided by employees will be treated as confidential medical information.
Yes. Exelon contacted contract vendors to discuss these new protocols. To be eligible to be exempt from mask and social distancing requirements at an Exelon site or while performing Exelon work in the field, contract vendors must agree to comply with Exelon’s new protocols. Contractors, other than onsite staff augmentation providers, are managing their process of documenting vaccination status and distributing stickers/buttons separately. Supplier-managed contractors should not email OHSRequests@exeloncorp.com or input their vaccination documentation into the HR Solutions Hub.
Yes. If you are a staff augmentation worker, you should email OHSRequests@exeloncorp.com to provide vaccination documentation.
Exelon will manage the process of reviewing vaccination documentation submitted by staff augmentation workers to OHSRequests@exeloncorp.com and distributing stickers/buttons to workers classified as staff augmentation following the OpCo or location process for sticker/button distribution.
Staff augmentation workers cannot input their vaccination documentation directly into the HR Solutions Hub and must email OHSRequests@exeloncorp.com.
According to the CDC, “people are considered fully vaccinated:
Two weeks after their second dose in a two-dose series, such as the Pfizer or Moderna vaccines
Two weeks after a single-dose vaccine, such as Johnson & Johnson’s Janssen vaccine
If an employee does not meet these requirements, they are not fully vaccinated and must continue to follow all COVID-19 safety protocols.
Return to the person who originally provided your sticker/button to obtain a new sticker.
In the meantime, wear a mask and social distance in accordance with applicable safety protocols. Please remember that the “It’s Time” stickers/buttons are non-transferable and cannot be shared with another employee, contractor, or other individual at any time for any reason.
COVID-19 is still considered a global pandemic and poses serious health risks, especially to those yet to be vaccinated. Exelon takes these risks seriously and continues to align its policies with CDC recommendations and guidance.
When the CDC determines that it safe for unvaccinated people to stop wearing masks in the workplace, Exelon will evaluate its safety protocols for non-vaccinated employees, which also will take into consideration state and local requirements.
Yes. Exelon will continue to re-evaluate and can suspend exceptions from safety protocols as needed to ensure the safety of employees, contractors and the public.
No. The CDC recommends the COVID vaccine even if you have already had COVID-19 and recovered. This is because experts do not yet know how long you are protected from getting sick again after recovering from COVID-19. Even if you have already recovered from COVID-19, it is possible that you could be infected with the virus that causes COVID-19 again. So, stickers/buttons will only be provided to those who provide documentation that they are fully vaccinated.
If a booster is recommended or required by the CDC or state or local protocols, Exelon will re-evaluate its safety protocols and exceptions from safety protocols accordingly.
No. Each vaccine approved by the FDA underwent rigorous trials with tens of thousands of participants. The entire process went faster than usual, but still followed the usual steps for testing and review. The most important reasons for speed: modern scientific tools are faster than old ones, and there was a worldwide effort to reduce or remove the usual barriers and delays in vaccine research, production and distribution. A large number of ordinary people volunteered for clinical trials of the vaccines, which meant we got the answers to key questions about safety and protection quickly.
The vaccines still received independent review and approval under emergency rules put in place before this pandemic for situations where the public’s health is at serious and immediate risk, as it is now.
If you have questions about the vaccine, please make sure to reach out to a credible, trustworthy source, such as your healthcare provider, for answers and check out our Vax Scene employee site.
Many people believe that the Pfizer and Moderna vaccine is new “science,” but the mRNA technology has been around for a couple of decades. There also has been a lot of work done historically to create a vaccine for coronaviruses. Just to be clear, the mRNA vaccines cannot change your DNA. While it does enter into a cell, it does not enter the nucleus of the cell. Finally, the Johnson & Johnson vaccine uses an older technology, which has been previously tested and used in
other types of vaccines.
We all want to return to normal and vaccinations are a way to do that, but it will take some time. It’s the nature of a virus to circulate and to mutate.
The science is indicating this virus will be endemic and will continue to circulate, which makes it all the more important for us to control the virus instead of it controlling us. Getting vaccinated and following the guidelines from our public health experts are critical to ending the pandemic. But we can’t let our guard down yet. Together we can end this.
As a reminder, vaccine distribution information continues to evolve rapidly, so do check out the Vax Scene webpage and CDC site for updates or discuss with your health care provider.
No. You will not be disciplined if you decide not to get the vaccine. We expect that for the continued safety of our employees we will continue to require PPE until the risk of the virus has been greatly reduced in the general population.
The entire process went faster than usual for explainable reasons, but still followed the usual steps for testing and review. The most important reasons for speed: modern scientific tools are faster than old ones, and there was a worldwide effort to reduce or remove the usual barriers and delays in vaccine research, production and distribution. A large number of ordinary people volunteered for clinical trials of the vaccines, which meant we got the answers to key questions about safety and protection quickly.
The vaccines still received independent review and approval, under emergency rules put in place before this pandemic for situations where the public’s health is at serious and immediate risk, as it is now.
Excerpted from the University of Michigan Health blog.
Several variants have developed over the past year. The most notable, the delta strain, classified as a variant of concern (VOC), spreads from person to person more easily than other variants and may cause more severe illness. Although it's still possible for a vaccinated individual to contract COVID-19, research has shown that vaccines remain very effective against COVID-19 and variant-related hospitalization and death.
If you have individual concerns about how the vaccine may affect you, please talk with your health care provider. We strongly encourage all employees to be vaccinated, but it is not mandatory.
According to the CDC, while experts learn more about the protection COVID-19 vaccines provide under real-life conditions, it will be important for everyone to continue following CDC guidance and using appropriate tools available to us to help stop this pandemic, which for unvaccinated means things like covering your mouth and nose with a mask, washing hands often, and staying at least six feet away from others. Together, COVID-19 vaccination and following CDC’s recommendations for how to protect yourself and others will offer the best protection from getting and spreading COVID-19.
Most people experience only mild side effects for a day or two. Please contact your health care provider if you have questions. If you are ill and unable to work due to side effects, please report your absence in accordance with applicable absence reporting requirements.
Although very rare, some severe side effects, such as blood clots or the development of Guillain-Barre Syndrome have been reported. If you develop a severe headache, abdominal pain, leg pain and shortness of breath within three to 16 days of vaccination or severe muscle weakness or a tingling sensation within six weeks of vaccination, immediately contact your physician or seek medical attention as soon as possible.
The CDC created an advisory panel to evaluate the risks of the J&J vaccine, which is linked to blood clots and Guillain-Barre Syndrome. The panel found that the benefit of vaccination still outweighs the risk of developing severe side effects. The CDC and FDA continue to recommend all the individuals above age 12 receive and age-appropriate COVID-19 vaccination.
Phase 1 clinical trials focus on safety and include 20–100 healthy volunteers. In Phase 1, scientists begin to learn how the size of the dose may be related to side effects. At this early stage, scientists also try to learn how effective the vaccine may be. If no serious side effects are found in Phase 1 the trial moves on to Phase 2.
Clinical trials are conducted according to plans that FDA reviews to ensure the highest scientific and ethical standards. The results of the clinical trials are a part of FDA’s evaluation to assess the safety and effectiveness of each vaccine. In addition to evaluating the results of the clinical trials, FDA scientists and medical professionals carefully evaluate a wide range of information including results of studies on the vaccine’s physical, chemical and biological properties, as well as how it is manufactured, to ensure that it can be made consistently safe, pure and potent.